Waters stock tracks its core lab testing business.
03.07.2026 - 18:40:57 | ad-hoc-news.de
By Julia Smith, Sector & Peers desk. Reviewed on July 3, 2026 at 4:40 p.m. ET.
Waters Corp (ISIN US9418481035) is a New York Stock Exchange-listed laboratory instruments company focused on analytical systems used in life sciences, materials, and applied markets. Its core business centers on liquid chromatography and mass spectrometry platforms, which are used to separate, identify, and quantify chemical compounds.
Core business
Waters sells instruments, software, consumables, and service contracts around that installed base, which gives the company a recurring-revenue layer beyond equipment sales. That mix matters for investors because the replacement cycle and lab spending trends tend to shape order timing and margins.
US market anchor
The company trades in the US on the New York Stock Exchange under WAT, giving it a clear domestic market reference for investors following industrial and life-science equipment names. Waters also sits in the same broad US analytical-instruments conversation as other suppliers serving regulated research and quality-control labs.
Waters business model and shareholder context
Read more on Waters' market profile, business lines, and investor background.
Product focus
One representative product area is the company's chromatography systems, which are central to routine analysis in pharmaceutical development and quality testing. Those instruments help labs separate compounds and support the workflows that feed Waters' recurring consumables and service revenue.
Stock snapshot
As of July 3, 2026, 4:40 p.m. ET, no live price was provided in the available search results, so the article stays with the company's operating profile and exchange listing.
Waters Corp fact box
- Company: Waters Corp
- ISIN: US9418481035
- Ticker: WAT
- Exchange: New York Stock Exchange
- Sector / Industry: Life sciences tools and services / analytical instruments
- Index membership: not verified in the available source set
- Next earnings date: not yet officially scheduled
This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.
